IMV Announces Initial Winners of 2025 ServiceTrak™ Clinical Laboratory Awards, Honored at ADLM Annual Conference 

/in /by

[ARLINGTON, VA., July 28, 2024] — IMV, part of the Science and Medicine Group and the leading market research and business intelligence provider to the laboratory diagnostic industry, is pleased to announce the initial winners of the 2024–2025 IMV ServiceTrak™ Clinical Laboratory Awards. These prestigious awards celebrate industry excellence by recognizing top clinical laboratory manufacturers across multiple instrument categories. 

Award presentations will take place July 27–31, 2024, during the ADLM Annual Conference in Chicago, IL — a premier event for laboratory professionals. 

Each year, laboratory professionals from more than 1,150 clinical testing locations, representing 1,900 instruments, rate their satisfaction with manufacturers in three key performance categories:  

  • Best Customer Satisfaction: highest likelihood of repeat purchase 
  • Best System Performance: highest overall system performance rating 
  • Best Service: highest overall OEM service rating 

The 2024–2025 awards are based on this direct feedback. The initial group of awardees includes top-performing manufacturers in Chemistry, Immunoassay, and Integrated Systems. Additional modalities and category winners will be announced in the coming months.  

🏆 2024–2025 IMV ServiceTrak™ Clinical Laboratory Award Winners (Initial Round) 

Chemistry 

  • Best Service: Roche 
  • Best Customer Satisfaction: Roche 
  • Best System Performance: Roche, QuidelOrtho 

Immunoassay 

  • Best Customer Satisfaction: Roche 
  • Best Service: bioMérieux, Inc. 
  • Best System Performance: bioMérieux, Inc. 

Integrated Systems 

  • Best Customer Satisfaction: Roche 
  • Best System Performance: Roche, QuidelOrtho 
  • Best Service: Roche, QuidelOrtho 

About IMV’s ServiceTrak™ Program 

IMV, part of Science and Medicine Group, produces an annual series of proprietary ServiceTrak™ Clinical Laboratory reports derived from extensive phone and online interviews with laboratory testing professionals in U.S. hospitals. These reports present an independent analysis of service trends in laboratory diagnostics and include manufacturer ratings for each instrument type. 

  • Rating Scale: Satisfaction is rated on a 10-point scale (10 = “excellent,” 1 = “very poor”) 
  • Highly Satisfied (%HS): Ratings of 9 or 10 
  • Award Criteria: Awards are given to manufacturers with the highest %HS scores in Customer Satisfaction, System Performance, and Service 
  • Highly Satisfied (%HS): Responses of 9 or 10 are considered “highly satisfied.” 

IMV ServiceTrak™ has been an industry benchmarking standard for more than 25 years, capturing the customer experience from installation to end-of-life. 

About IMV 

IMV Medical Information Division, established in 1977, is a trusted marketing research and consulting firm that specializes in the dynamic fields of diagnostic imaging and clinical diagnostics. Our commitment to in-depth market analysis and comprehensive research services empowers clients to excel in strategic planning, enhance customer satisfaction, drive product development, and launch successful sales initiatives. All of IMV’s reports and data solutions are based on primary research by diagnostic imaging experts. As a reliable provider of market intelligence, IMV gives you the comprehensive information you need to stay two steps ahead and make decisions with confidence!  

For media inquires or to learn more about IMV’s ServiceTrak reports, please contact: 

Media Contact
IMV Marketing
(703) 778-3080
www.imvinfo.com
[email protected]   

Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain 

/in /by

Arlington, VA — June 2025 — A new survey of 195 diagnostic imaging and clinical lab professionals reveals that tariff policy uncertainty is already changing how providers plan staffing, purchasing, and vendor relationships. The latest Beyond the Bench survey report from IMV, a Science and Medicine Group company, highlights how healthcare organizations are bracing for the financial ripple effects of U.S. tariffs—despite many not yet feeling the full impact. 

 Download the Full Tariff Impact Survey Summary 

While 69% of respondents say tariffs haven’t yet impacted technology investments, the majority expect serious disruption across their operations. Nearly one-third anticipate severe delays in supplies, and 25% expect cost spikes in goods and equipment. Nearly half of respondents say their department has no plan in place to offset rising costs. 

Key Insights: 

  • 33% expect extreme disruption in supply chains due to tariffs 
  • Only 30% have active mitigation plans—most cite hiring pauses, vendor changes, or reduced purchasing 
  • Staffing and reimbursement challenges are already weighing heavily, even before tariffs fully take effect 

These findings reflect an industry already stretched thin—and now preparing for yet another wave of financial pressure. As one respondent noted: “We’re delaying capital purchases and reconsidering our supplier strategy. Costs are rising across the board, and tariffs are only making it harder to plan.” 

Department Leaders Are Weighing Tough Trade-Offs 

Among departments that have begun planning, the top strategies include: 

  • Hiring freezes or staff reductions 
  • Pausing purchases or delaying upgrades 
  • Changing vendors to cut costs 
  • Passing on costs through patient billing 

But with nearly 50% of respondents citing “no plan in place,” this data shows an urgent need for healthcare providers—and their vendors—to align on solutions that address cost control, supply flexibility, and long-term resilience. 

“These results are an early warning signal,” said Richa Singh, VP of Insight Accounts. “Many departments are walking a tightrope between cost pressures, staffing shortages, and policy changes that are still evolving. Vendors who understand these headwinds will be best positioned to support their provider partners with flexible pricing, streamlined procurement, and more strategic partnerships.” 

Join the Science Advisory Board – qualify to participate in future surveys, earn rewards, and shape the future of scientific research:  

 

About Beyond the Bench 

Beyond the Bench is a free monthly intelligence series produced by BioInformatics. Powered by the Science Advisory Board—their proprietary global network of over 55,000 life science and diagnostic professionals—each report delivers timely, survey-based insights on the commercial realities and market shifts facing healthcare providers today. 

Sign up to receive free monthly survey insights: Subscribe to Beyond the Bench   

Who’s Servicing Your PET Systems? New Data Reveals OEMs Still Dominate, but In-House and ISO Support Varies by Site Type

/in /by

Service support decisions can significantly impact the performance, uptime, and total cost of ownership of PET systems. According to IMV’s newly released 2025 PET Market Summary Report, original equipment manufacturers (OEMs) continue to dominate the service landscape in 2024, supporting 75% of systems nationwide. However, a deeper look at facility-level data reveals meaningful variation in service strategies—especially among large hospitals and independent PET sites. Understanding these trends is essential for imaging leaders evaluating service options and contract models for their post-warranty systems.

IMV: PET procedure volumes continue strong growth trend 

/in /by

Davin Korstjens 

Apr 10, 2025 

Overall PET procedure volumes increased by 12.2% in 2024 compared with 2023, according to the newly published IMV 2025 PET Market Summary Report. 

Over the same period between the two years, the average number of PET scans performed per installed fixed PET/CT systems increased by 8.2% — a finding that indicates that much of the increased procedure volumes have been absorbed by existing PET system capacity. 

Davin Korstjens of IMV Medical Information Division. 

For sites with a fixed PET/CT system, there is an annual average of 336 PET scans read per physician per site. This ranges from a high of 567 scans per physician in over 400 bed hospitals, to a low of 119 in under 200 bed hospitals. 

Average Annual PET Imaging Scans Read per Physician per Site 
Site Type  Scans 
All fixed PET Sites  336 
Under 200 bed hospitals  119 
200 to 399 bed hospitals  243 
More than 400 bed hospitals  567 
Hospital-owned imaging centers  260 
Independent imaging centers  285 

 

Regarding the physician types that read PET scans, general radiologists read these exams at 69% of sites, nuclear medicine physicians at 51% of sites, and cardiologists or nuclear cardiologists at 11% of sites. The top referring physicians sending patients for PET scans are medical oncologists, radiation oncologists, and pulmonologists. 

Overall, 40% of responding sites had a wait time of eight or more days for nonemergency outpatient PET scans, which was relatively flat year-over-year. However, this percentage is up 21 percentage points from 2019, when just 19% of responding sites had a wait time of eight or more days. 

Taken together, increasing procedure volumes, higher capacity use of installed PET systems, and longer wait times for procedures suggest that sites may need to expand PET imaging capacity to meet increasing demand for these procedures going forward. 

Follow IMV Medical Information on LinkedIn for more diagnostic imaging updates. 

Davin Korstjens is the Director of Market Intelligence at IMV Medical Information Division, part of Science and Medicine Group. 

Want to share your knowledge of medical imaging? Click here to sign up for the IMV Survey panel today. 

IMV’s 2025 PET Market Summary Report explores market trends in U.S. hospitals and imaging centers, including procedure volume, manufacturer installed base features and share, the use of OEM vs. third-party service providers, purchase plans, brand loyalty, and site operations characteristics. The report was published in March 2025 and is based on responses from 509 radiology/departmental administrators and clinicians who participated in IMV’s nationwide survey from February 2024 to January 2025. Vendors covered in this report include Bracco, Canon, Cardinal Health, GEHC, Jubilant/Draximage/Triad Isotopes, PharmaLogic, Philips, Siemens, SOFIE/IBA/Eastern Isotopes, United Imaging. 

For information about purchasing IMV Market Outlook Reports, visit the corporate website at https://imvinfo.com/ or call 703-778-3080 ext. 1033 to speak with a representative. 

Disclosure: IMV Medical Information Division is a sister company of AuntMinnie.com. 

 

IMV Data Cited in JAMA Report on CT Imaging and Cancer Risk

/in /by

The blog article featured below was originally published by our sister company, AuntMinnie.com, and highlights a recent JAMA Network Open study on the projected impact of CT imaging on future cancer cases. Notably, the JAMA report relies on imaging utilization data sourced from IMV’s CT Market Outlook research.

IMV is proud to provide trusted market data that supports critical healthcare research and informs thought leadership across the industry. The inclusion of IMV’s data in a peer-reviewed publication by the American Medical Association underscores the trust and credibility our insights bring to key conversations in medical imaging.

JAMA:  Projected Lifetime Cancer Risks from CT Imaging